PepVax Announces Filing of Provisional Patent Application for SMARTmid DNA Platform and Other Updates

BETHESDA, Md., March 6, 2018 /PRNewswire/ -- PepVax, Inc., an early-stage biotechnology company, announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office (USPTO) pertaining to SMARTmid™ DNA platform. The Company is harnessing the power...